Chancellor Reeves has revealed she is preparing "focused measures to deal with household expense challenges" in the upcoming financial statement.
Speaking to media outlets, she noted that reducing price rises is a shared task of both the government and the central bank.
The United Kingdom's inflation rate is projected to be the highest among the Group of Seven advanced economies this calendar year and the following year.
Potential Energy Cost Interventions
Sources suggest the administration could intervene to lower utility costs, such as by reducing the present 5% level of value-added tax applied on energy supplies.
A further option is to reduce some of the policy costs currently added to bills.
Budgetary Constraints and Analyst Predictions
The government will receive the latest report from the independent fiscal watchdog, the OBR, on Monday, which will reveal how much room there is for such actions.
The expectation from most economists is that Reeves will have to announce tax increases or budget cuts in order to meet her voluntary fiscal targets.
Earlier on Thursday, estimates showed there was a twenty-two billion pound deficit for the Treasury chief to fill, which is at the more modest range of forecasts.
"There's a collective job between the Bank of England and the government to bear down further on some of the sources of inflation," the Chancellor informed reporters in Washington, at the annual meetings of the IMF and global financial institution.
Revenue Commitments and Global Issues
While much of the attention has been on probable tax rises, the Treasury chief said the most recent information from the OBR had not changed her pledge to manifesto promises not to increase rates on earnings tax, sales tax or social security contributions.
She blamed an "uncertain world" with rising international and commercial issues for the fiscal revenue measures, probably to be focused on those "with the broadest shoulders."
International Economic Tensions
Commenting on apprehensions about the United Kingdom's commercial links with the Asian nation she said: "Our national security always take priority."
Last week's statement by China to tighten trade restrictions on rare earths and other resources that are essential for high-technology manufacturing led US President Donald Trump to threaten an extra 100% import tax on goods from China, raising the possibility of an full-scale trade war between the two global powers.
The American finance chief called China's action "commercial pressure" and "a international production control attempt."
Asked about accepting the US offer to participate in its conflict with the Asian nation, Reeves said she was "deeply worried" by Chinese actions and urged the Chinese government "not to put up barriers and restrict access."
She said the action was "harmful for the global economy and creates additional challenges."
"In my view there are sectors where we need to confront Chinese policies, but there are also important opportunities to trade with Chinese markets, including financial services and other sectors of the economy. We've got to maintain that equilibrium right."
The chancellor also affirmed she was working with G7 counterparts "on our own essential resources strategy, so that we are more independent."
Health Service Medicine Costs and Investment
Reeves also recognized that the cost the NHS pays for pharmaceuticals could go up as a result of ongoing negotiations with the US government and its drugs companies, in exchange for lower tariffs and funding.
A number of the world's largest pharmaceutical manufacturers have said recently that they are either pausing or abandoning operations in the United Kingdom, with some attributing the modest returns they are receiving.
Recently, the government science advisor said the price the health service pays for medicines would have to increase to prevent businesses and pharmaceutical investment leaving the United Kingdom.
The Chancellor told the BBC: "We have seen due to the pricing regime, that drug testing, innovative medicines have not been offered in the UK in the extent that they are in other European countries."
"We want to ensure that individuals receiving care from the NHS are able to access the finest essential drugs in the globe. And so we are looking at these issues, and... aiming to secure increased capital into the UK."
